Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dr. Lal PathLabs has informed that the details of proposed schedule of Analyst/ Institutional Investor meeting(s) as on December 5, 2022, and December 6, 2022 are enclosed.
The above information is a part of company’s filings submitted to BSE.